Toll-like receptor-mediated immune responses are attenuated in the presence of high levels of hepatitis B virus surface antigen

Journal of Viral Hepatitis

Volumn 21, Issue 12, 2014, Pages 860-872

  Jiang, M ^a,b   Broering, R ^a   Trippler, M ^a   Poggenpohl, L ^a   Fiedler, M ^a   Gerken, G ^a   Lu, M ^a   Schlaak, J F ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

adaptive immunity; chronic hepatitis B; immunoregulation; innate immunity; non parenchymal liver cells

Indexed keywords

GAMMA INTERFERON; HEPATITIS B SURFACE ANTIGEN; INTERFERON; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; CYTOKINE;

ADAPTIVE IMMUNITY; ADULT; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INNATE IMMUNITY; KUPFFER CELL; LISTERIA MONOCYTOGENES; LIVER CELL; MALE; MIXED LYMPHOCYTE REACTION; MONONUCLEAR CELL; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PERSISTENT INFECTION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; T LYMPHOCYTE ACTIVATION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; ENDOTHELIUM CELL; GENE EXPRESSION PROFILING; IMMUNOLOGY; SECRETION (PROCESS); VIROLOGY;

ADULT; ANIMALS; BLOTTING, WESTERN; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B, CHRONIC; HUMANS; KUPFFER CELLS; LEUKOCYTES, MONONUCLEAR; MALE; MICE, INBRED BALB C; MICE, INBRED C57BL; REAL-TIME POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTORS;

EID: 84910635824     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12216     Document Type: Article

References (35)

1. Lavanchy D,. Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention. J Clin Virol 2005; 34 (Suppl. 1): S1-S3.
2. Ganem D, Prince AM,. Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350 (11): 1118-1129.
3. Bertoletti A, Gehring AJ,. The immune response during hepatitis B virus infection. J Gen Virol 2006; 87 (Pt 6): 1439-1449.
4. Broering R, Lu M, Schlaak JF,. Role of Toll-like receptors in liver health and disease. Clin Sci (Lond) 2011; 121 (10): 415-426.
5. Wieland S, Thimme R, Purcell RH, Chisari FV,. Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 2004; 101 (17): 6669-6674.
6. Wieland SF, Chisari FV,. Stealth and cunning: hepatitis B and hepatitis C viruses. J Virol 2005; 79 (15): 9369-9380.
7. Fisicaro P, Valdatta C, Boni C, et al,. Early kinetics of innate and adaptive immune responses during hepatitis B virus infection. Gut 2009; 58 (7): 974-982.
8. Vanlandschoot P, Roobrouck A, Van HF, Leroux-Roels G,. Recombinant HBsAg, an apoptotic-like lipoprotein, interferes with the LPS-induced activation of ERK-1/2 and JNK-1/2 in monocytes. Biochem Biophys Res Commun 2002; 297 (3): 486-491.
9. Xu Y, Hu Y, Shi B, et al,. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells. Mol Immunol 2009; 46 (13): 2640-2646.
10. Reignat S, Webster GJ, Brown D, et al,. Escaping high viral load exhaustion: CD8 cells with altered tetramer binding in chronic hepatitis B virus infection. J Exp Med 2002; 195 (9): 1089-1101.
11. Thompson AJ, Colledge D, Rodgers S, et al,. Stimulation of the interleukin-1 receptor and Toll-like receptor 2 inhibits hepatitis B virus replication in hepatoma cell lines in vitro. Antivir Ther 2009; 14 (6): 797-808.
12. Wu J, Lu M, Meng Z, et al,. Toll-like receptor-mediated control of HBV replication by nonparenchymal liver cells in mice. Hepatology 2007; 46 (6): 1769-1778.
13. Wu J, Meng Z, Jiang M, et al,. HBV suppresses toll-like receptor mediated innate immune responses in murine parenchymal and non-parenchymal liver cells. Hepatology 2009; 49 (4): 1132-1140.
14. Umeda M, Marusawa H, Seno H, et al,. Hepatitis B virus infection in lymphatic tissues in inactive hepatitis B carriers. J Hepatol 2005; 42 (6): 806-812.
15. Petersen J, Ratziu V, Buti M, et al,. Entecavir plus tenofovir combination as rescue therapy in pre-treated chronic hepatitis B patients: an international multicenter cohort study. J Hepatol 2012; 56 (3): 520-526.
16. Lada O, Gervais A, Branger M, et al,. Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G. Liver Int 2012; 32 (1): 93-101.
17. Broering R, Wu J, Meng Z, et al,. Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication. J Hepatol 2008; 48 (6): 914-922.
18. Seki E, Brenner DA,. Toll-like receptors and adaptor molecules in liver disease: update. Hepatology 2008; 48 (1): 322-335.
19. Mitchell D, Olive C,. Regulation of Toll-like receptor-induced chemokine production in murine dendritic cells by mitogen-activated protein kinases. Mol Immunol 2010; 47 (11-12): 2065-2073.
20. Liu Y, Kimura K, Yanai R, Chikama T, Nishida T,. Cytokine, chemokine, and adhesion molecule expression mediated by MAPKs in human corneal fibroblasts exposed to poly(I:C). Invest Ophthalmol Vis Sci 2008; 49 (8): 3336-3344.
21. Ermolaeva MA, Michallet MC, Papadopoulou N, et al,. Function of TRADD in tumor necrosis factor receptor 1 signaling and in TRIF-dependent inflammatory responses. Nat Immunol 2008; 9 (9): 1037-1046.
22. Schrofelbauer B, Raffetseder J, Hauner M, Wolkerstorfer A, Ernst W, Szolar OH,. Glycyrrhizin, the main active compound in liquorice, attenuates pro-inflammatory responses by interfering with membrane-dependent receptor signalling. Biochem J 2009; 421 (3): 473-482.
23. Steer SA, Moran JM, Christmann BS, Maggi LB Jr, Corbett JA,. Role of MAPK in the regulation of double-stranded RNA- and encephalomyocarditis virus-induced cyclooxygenase-2 expression by macrophages. J Immunol 2006; 177 (5): 3413-3420.
24. Wu J, Meng Z, Jiang M, et al,. Toll-like receptor-induced innate immune responses in non-parenchymal liver cells are cell type-specific. Immunology 2010; 129 (3): 363-374.
25. Wang S, Chen Z, Hu C, et al,. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation. J Immunol 2013; 190 (10): 5142-5151.
26. Shi B, Ren G, Hu Y, Wang S, Zhang Z, Yuan Z,. HBsAg inhibits IFN-alpha production in plasmacytoid dendritic cells through TNF-alpha and IL-10 induction in monocytes. PLoS One 2012; 7 (9): e44900.
27. Murray JM, Wieland SF, Purcell RH, Chisari FV,. Dynamics of hepatitis B virus clearance in chimpanzees. Proc Natl Acad Sci USA 2005; 102 (49): 17780-17785.
28. Knolle PA, Gerken G,. Local control of the immune response in the liver. Immunol Rev 2000; 174: 21-34.
29. Kimura K, Kakimi K, Wieland S, Guidotti LG, Chisari FV,. Activated intrahepatic antigen-presenting cells inhibit hepatitis B virus replication in the liver of transgenic mice. J Immunol 2002; 169 (9): 5188-5195.
30. Lu Y, Xu Y, Yang D, Kemper T, Roggendorf M, Lu M,. Molecular characterization of woodchuck type I interferons and their expression by woodchuck peripheral blood lymphocytes. Cytokine 2008; 41 (2): 127-135.
31. Lucifora J, Durantel D, Testoni B, Hantz O, Levrero M, Zoulim F,. Control of hepatitis B virus replication by innate response of HepaRG cells. Hepatology 2010; 51 (1): 63-72.
32. Cheng J, Imanishi H, Morisaki H, et al,. Recombinant HBsAg inhibits LPS-induced COX-2 expression and IL-18 production by interfering with the NFkappaB pathway in a human monocytic cell line, THP-1. J Hepatol 2005; 43 (3): 465-471.
33. Riordan SM, Skinner N, Kurtovic J, Locarnini S, Visvanathan K,. Reduced expression of toll-like receptor 2 on peripheral monocytes in patients with chronic hepatitis B. Clin Vaccine Immunol 2006; 13 (8): 972-974.
34. Visvanathan K, Skinner NA, Thompson AJ, et al,. Regulation of Toll-like receptor-2 expression in chronic hepatitis B by the precore protein. Hepatology 2007; 45 (1): 102-110.
35. Brunetto MR, Moriconi F, Bonino F, et al,. Hepatitis B virus surface antigen levels: a guide to sustained response to peginterferon alfa-2a in HBeAg-negative chronic hepatitis B. Hepatology 2009; 49 (4): 1141-1150.